The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Histone deacetylase inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Cellular Memory and the Histone Code
Turner, B. M. (2002) · Cell · doi:10.1016/s0092-8674(02)01080-2 · Cited by 1,142
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914
(2002) · PubMed · Cited by 732
Yoshida, M., Horinouchi, S., & Beppu, T. (1995) · BioEssays · doi:10.1002/bies.950170510 · Cited by 713
Saito, A., Yamashita, T., Mariko, Y., Nosaka, Y., Tsuchiya, K., Ando, T., Suzuki, T., Tsuruo, T., & Nakanishi, O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4592 · Cited by 694
Butler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
Histone acetylases and deacetylases in cell proliferation
Kouzarides, T. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80006-9 · Cited by 601
Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase
Darkin-Rattray, S. J., Gurnett, A. M., Myers, R. W., Dulski, P. M., Crumley, T. M., Allocco, J. J., Cannova, C., Meinke, P. T., Colletti, S. L., Bednarek, M. A., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13143 · Cited by 575
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., & Schreiber, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106779200 · Cited by 539
Histone deacetylase inhibitors as new cancer drugs
Marks, P. A., Richon, V. M., Breslow, R., & Rifkind, R. A. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00010 · Cited by 531
Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., & Beppu, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41547-5 · Cited by 514
UEDA, H., NAKAJIMA, H., HORI, Y., FUJITA, T., NISHIMURA, M., GOTO, T., & OKUHARA, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.301 · Cited by 489
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
Structure of the histone deacetylase SIRT2.
Finnin, M. S., Donigian, J. R., & Pavletich, N. P. (2001) · Nature Structural Biology · doi:10.1038/89668 · Cited by 435
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Furumai, R., Komatsu, Y., Nishino, N., Khochbin, S., Yoshida, M., & Horinouchi, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.87 · Cited by 412
Histone acetylation reduces nucleosome core particle linking number change
Norton, V. G., Imai, B. S., Yau, P., & Bradbury, E. M. (1989) · Cell · doi:10.1016/0092-8674(89)90920-3 · Cited by 396
Identification of a small molecule inhibitor of Sir2p
Bedalov, A., Gatbonton, T., Irvine, W. P., Gottschling, D. E., & Simon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261574398 · Cited by 346
Marks, P. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00084-5 · Cited by 344
A new antifungal antibiotic, trichostatin.
TSUJI, N., KOBAYASHI, M., NAGASHIMA, K., WAKISAKA, Y., & KOIZUMI, K. (1976) · The Journal of Antibiotics · doi:10.7164/antibiotics.29.1 · Cited by 341
Effect of sodium butyrate on mammalian cells in culture: A review
Prasad, K. N., & Sinha, P. K. (1976) · In Vitro · doi:10.1007/bf02796360 · Cited by 327
Plumb, J. A., Finn, P. W., Williams, R. J., Bandara, M. J., Romero, M., Watkins, C. J., Thangue, N. B. L., & Brown, R. E. (2003) · PubMed · Cited by 312
Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.
Guan, R. J., Ford, H. L., Fu, Y., Li, Y., Shaw, L. M., & Pardee, A. B. (2000) · PubMed · Cited by 311
Fuino, L., Bali, P., Wittmann, S., Donapaty, S., Guo, F., Yamaguchi, H., Wang, H., Atadja, P. W., & Bhalla, K. N. (2003) · PubMed · Cited by 296
Synthesis and Histone Deacetylase Inhibitory Activity of New Benzamide Derivatives
Suzuki, T., Ando, T., Tsuchiya, K., Fukazawa, N., Saito, A., Mariko, Y., Yamashita, T., & Nakanishi, O. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980565u · Cited by 293
Nimmanapalli, R., Fuino, L., Bali, P., Gasparetto, M., Glozak, M. A., Tao, J., Moscinski, L. C., Smith, C. A., Wu, J., Jove, R., et al. (2003) · PubMed · Cited by 276
Han, J. W., Ahn, S. H., Park, S. H., Wang, S. Y., Bae, G., Seo, D. W., Kwon, H. K., Hong, S., Lee, H. Y., Lee, Y., et al. (2000) · PubMed · Cited by 273
Histone deacetylase inhibitors: from target to clinical trials
Kelly, W. K., O’Connor, O. A., & Marks, P. A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1695 · Cited by 253
Histone deacetylase inhibitors: Understanding a new wave of anticancer agents
Villar‐Garea, A., & Esteller, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20372 · Cited by 247
Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart, M. J., Tainton, K. M., Ruefli, A. A., Dear, A. E., Sedelies, K. A., O’Reilly, L. A., Waterhouse, N. J., Trapani, J. A., & Johnstone, R. W. (2003) · PubMed · Cited by 233
Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
Kim, Y. B., Lee, K.-H., Sugita, K., Yoshida, M., & Horinouchi, S. (1999) · Oncogene · doi:10.1038/sj.onc.1202564 · Cited by 232
Butyric acid: A small fatty acid with diverse biological functions
Prasad, K. N. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90397-5 · Cited by 229
Kwon, S. H., Ahn, S. H., Kim, Y. K., Bae, G.-U., Yoon, J. W., Hong, S., Lee, H. Y., Lee, Y.-W., Lee, H.-W., & Han, J.-W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106699200 · Cited by 215
Haggarty, S. J., Koeller, K. M., Wong, J. C., Butcher, R. A., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00095-4 · Cited by 201
ITAZAKI, H., NAGASHIMA, K., SUGITA, K., YOSHIDA, H., KAWAMURA, Y., YASUDA, Y., MATSUMOTO, K., ISHII, K., UOTANI, N., NAKAI, H., et al. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.1524 · Cited by 197
Kwon, H. J., Owa, T., Hassig, C. A., Shimada, J., & Schreiber, S. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3356 · Cited by 197
Taunton, J., Collins, J. L., & Schreiber, S. L. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9615841 · Cited by 192
Su, G. H., Sohn, T. A., Ryu, B., & Kern, S. E. (2000) · PubMed · Cited by 189
Jung, M., Brosch, G., Kölle, D., Scherf, H., Gerhäuser, C., & Loidl, P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991091h · Cited by 176
Effects of trichostatins on differentiation of murine erythroleukemia cells.
Yoshida, M., Nomura, S., & Beppu, T. (1987) · PubMed · Cited by 169
Total Synthesis of the Antitumor Depsipeptide FR-901,228
Li, K. W., Wu, J. J., Xing, W., & Simon, J. A. (1996) · Journal of the American Chemical Society · doi:10.1021/ja9613724 · Cited by 167
Singh, S. B., Zink, D. L., Liesch, J. M., Mosley, R. T., Dombrowski, A. W., Bills, G. F., Darkin‐Rattray, S. J., Schmatz, D. M., & GOETZ, M. A. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo016088w · Cited by 150
Trifluoromethyl ketones as inhibitors of histone deacetylase
Frey, R. R., Wada, C. K., Garland, R. B., Curtin, M. L., Michaelides, M. R., Li, J., Pease, L. J., Glaser, K. B., Marcotte, P. A., Bouska, J. J., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00754-0 · Cited by 149
Wang, D., Wiest, O., Helquist, P. M., Lan-Hargest, H.-Y., & Wiech, N. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0498497 · Cited by 145
Sternson, S. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2001) · Organic Letters · doi:10.1021/ol016915f · Cited by 145
Komatsu, Y., Tomizaki, K., Tsukamoto, M., Kato, T., Nishino, N., Sato, S., Yamori, T., Tsuruo, T., Furumai, R., Yoshida, M., et al. (2001) · PubMed · Cited by 145
Chronic Oral Administration of CI-994: A Phase I Study
Prakash, S., Foster, B. J., Meyer, M., Wozniak, A., Heilbrun, L. K., Flaherty, L. E., Zalupski, M. M., Radulovic, L. L., Valdivieso, M., & LoRusso, P. M. (2001) · Investigational New Drugs · doi:10.1023/a:1006489328324 · Cited by 136
Remiszewski, S., Sambucetti, L. C., Bair, K. W., Bontempo, J., Cesarz, D., Chandramouli, N., Chen, R., Cheung, M., Cornell-Kennon, S., Dean, K., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030235w · Cited by 130
Butyrate as a differentiating agent: pharmacokinetics, analogues and current status
Newmark, H. L., Lupton, J. R., & Young, C. W. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90023-x · Cited by 129
Structural Biasing Elements for In-Cell Histone Deacetylase Paralog Selectivity
Wong, J. C., Hong, R., & Schreiber, S. L. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0341440 · Cited by 115
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)
Curtin, M. L., Garland, R. B., Heyman, H. R., Frey, R. R., Michaelides, M. R., Li, J., Pease, L. J., Glaser, K. B., Marcotte, P. A., & Davidsen, S. K. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00622-4 · Cited by 115
Remiszewski, S., Sambucetti, L. C., Atadja, P. W., Bair, K. W., Cornell, W. D., Green, M. A., Howell, K. L., Jung, M., Kwon, P. O., Trogani, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm015568c · Cited by 113
Butyrate and phenylacetate as differentiating agents: Practical problems and opportunities
Newmark, H. L., & Young, C. W. (1995) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240590831 · Cited by 111
Histone deacetylase inhibitors – a new tool to treat cancer
Somech, R., Izraeli, S., & Simon, A. J. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.04.006 · Cited by 108
Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen, Z. X., & Tr, B. (1994) · PubMed · Cited by 104
Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells.
Mandal, M., & Kumar, R. (1996) · PubMed · Cited by 101
Analogues of trichosтatin a and trapoxin B as histone deacetylase inhibitors
Jung, M., Hoffmann, K., Brosch, G., & Loidl, P. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00284-9 · Cited by 91
Chemical Genetic Modifier Screens
Koeller, K. M., Haggarty, S. J., Perkins, B. D., Leykin, I., Wong, J. C., Kao, M.-C. J., & Schreiber, S. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00093-0 · Cited by 89
The Discovery of NVP-LAQ824: From Concept to Clinic
Remiszewski, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456675 · Cited by 88
α-Keto amides as inhibitors of histone deacetylase
Wada, C. K., Frey, R. R., Ji, Z., Curtin, M. L., Garland, R. B., Holms, J. H., Li, J., Pease, L. J., Guo, J., Glaser, K. B., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00685-1 · Cited by 84
Bouchain, G., & Delorme, D. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456585 · Cited by 80
Histone Deacetylase Inhibitors: The Abbott Experience
Curtin, M. L., & Glaser, K. B. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456576 · Cited by 78
Massa, S., Mai, A., Sbardella, G., Esposito, M., Ragno, R., Loidl, P., & Brosch, G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015515v · Cited by 73
Woo, S. H., Fréchette, S., Khalil, E. A., Bouchain, G., Vaisburg, A., Bernstein, N., Moradei, O. M., Leit, S. M., Allan, M., Fournel, M., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020154k · Cited by 73
Role of histone deacetylases in acute leukemia
Fenrick, R., & Hiebert, S. W. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<194::aid-jcb24>3.0.co;2-h · Cited by 73
Wittich, S., Scherf, H. R., Xie, C., Brosch, G., Loidl, P., Gerhäuser, C., & Jung, M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0208119 · Cited by 67
Design and synthesis of a novel class of histone deacetylase inhibitors
Lavoie, R., Bouchain, G., Fréchette, S., Woo, S. H., Khalil, E. A., Leit, S. M., Fournel, M., Yan, P. T., Trachy-Bourget, M.-C., Beaulieu, C., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00552-2 · Cited by 67
Kraker, A. J., Mizzen, C. A., Hartl, B. G., Miin, J., Allis, C. D., & Merriman, R. L. (2003) · PubMed · Cited by 64
Mai, A., Massa, S., Pezzi, R., Rotili, D., Loidl, P., & Brosch, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034167p · Cited by 60
Aviram, A., Zimrah, Y., Shaklai, M., Nudelman, A., & Rephaeli, A. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560625 · Cited by 52
Heterocyclic ketones as inhibitors of histone deacetylase
Vasudevan, A., Ji, Z., Frey, R. R., Wada, C. K., Steinman, D. H., Heyman, H. R., Guo, Y. P., Curtin, M. L., Guo, J., Li, J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.007 · Cited by 52
El-Beltagi, H. M., Martens, A. C., Lelieveld, P., Haroun, E. A., & Hagenbeek, A. (1993) · PubMed · Cited by 50
Dai, Y., Guo, Y. P., Curtin, M. L., Li, J., Pease, L. J., Guo, J., Marcotte, P. A., Glaser, K. B., Davidsen, S. K., & Michaelides, M. R. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.07.012 · Cited by 44
Suzuki, T., Nagano, Y., Matsuura, A., Kohara, A., Ninomiya, S.-I., Kohda, K., & Miyata, N. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.048 · Cited by 40
Uesato, S., Kitagawa, M., Nagaoka, Y., Maeda, T., Kuwajima, H., & Yamori, T. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00175-0 · Cited by 39
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Ommeslaeghe, K. V., Elaut, G., Brecx, V., Papeleu, P., Iterbeke, K., Geerlings, P., Tourwé, D., & Rogiers, V. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00284-1 · Cited by 27
Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogs of trichostatin A
Massa, S., Artico, M., Corelli, F., Mai, A., Santo, R. D., Cortes, S., Marongiu, M. E., Pani, A., & Colla, P. L. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00172a026 · Cited by 24
Synthesis and cellular characterization of the detransformation agent, (−)-depudecin
Shimada, J., Kwon, H. J., Sawamura, M., & Schreiber, S. L. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90185-x · Cited by 24
Glaser, K. B., Li, J., Aakre, M. E., Morgan, D. W., Sheppard, G. S., Stewart, K. D., Pollock, J. S., Lee, P., O'Connor, C. Z., Anderson, S. N., et al. (2002) · PubMed · Cited by 22
Seelig, M. H., & Berger, M. R. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00217-1 · Cited by 22
Lelieveld, P., Middeldorp, R. J. F., & Putten, L. M. V. (1985) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00257303 · Cited by 17
Cited by
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Deeley, R. G., Westlake, C., & Cole, S. P. C. (2006) · Physiological Reviews · doi:10.1152/physrev.00035.2005 · Cited by 761
Drug discovery from natural sources
Chin, Y.-W., Balunas, M. J., Chai, H. B., & Kinghorn, A. D. (2006) · The AAPS Journal · doi:10.1007/bf02854894 · Cited by 662
Suggested guidelines for the diagnosis and management of urea cycle disorders
Häberle, J., Boddaert, N., Burlina, A., Chakrapani, A., Dixon, M., Huemer, M., Karall, D., Martinelli, D., Crespo, P., Santer, R., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-32 · Cited by 628
Metadata
- Authors
- Monneret, C.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 40
- Issue
- 1
- Pages
- 1-13
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2952410637
- Cited by
- 338
- References
- 93
- FWCI
- 10.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.